BR9507438A - Composição oftálmica com viscosidade reduzida - Google Patents
Composição oftálmica com viscosidade reduzidaInfo
- Publication number
- BR9507438A BR9507438A BR9507438A BR9507438A BR9507438A BR 9507438 A BR9507438 A BR 9507438A BR 9507438 A BR9507438 A BR 9507438A BR 9507438 A BR9507438 A BR 9507438A BR 9507438 A BR9507438 A BR 9507438A
- Authority
- BR
- Brazil
- Prior art keywords
- amount
- pct
- weight
- viscosity
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9401108A SE9401108D0 (sv) | 1994-03-31 | 1994-03-31 | Ophthalmic composition I |
PCT/FI1995/000166 WO1995026711A1 (en) | 1994-03-31 | 1995-03-29 | Ophthalmic composition with decreased viscosity |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9507438A true BR9507438A (pt) | 1997-09-16 |
Family
ID=20393511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9507438A BR9507438A (pt) | 1994-03-31 | 1995-03-29 | Composição oftálmica com viscosidade reduzida |
Country Status (27)
Country | Link |
---|---|
US (1) | US5710182A (pt) |
EP (1) | EP0752847B1 (pt) |
JP (1) | JPH10503470A (pt) |
KR (1) | KR100365914B1 (pt) |
CN (1) | CN1112918C (pt) |
AT (1) | ATE202921T1 (pt) |
AU (1) | AU694497B2 (pt) |
BG (1) | BG63145B1 (pt) |
BR (1) | BR9507438A (pt) |
CA (1) | CA2186734A1 (pt) |
CZ (1) | CZ290987B6 (pt) |
DE (2) | DE69521686T2 (pt) |
DK (1) | DK0752847T3 (pt) |
EE (1) | EE03661B1 (pt) |
ES (1) | ES2161874T3 (pt) |
GR (1) | GR3036763T3 (pt) |
HK (1) | HK1013953A1 (pt) |
HU (1) | HU223071B1 (pt) |
MX (1) | MX9603918A (pt) |
NO (1) | NO314434B1 (pt) |
PL (1) | PL179433B1 (pt) |
PT (1) | PT752847E (pt) |
RO (1) | RO115409B1 (pt) |
RU (1) | RU2139016C1 (pt) |
SE (1) | SE9401108D0 (pt) |
SK (1) | SK280492B6 (pt) |
WO (1) | WO1995026711A1 (pt) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9718568D0 (en) | 1997-09-03 | 1997-11-05 | Chauvin Pharmaceuticals Limite | Compositions |
AU4808000A (en) | 1999-04-28 | 2000-11-10 | Situs Corporation | Drug delivery system |
US6852688B2 (en) | 2000-03-10 | 2005-02-08 | University Of Florida | Compositions for treating diabetic retinopathy and methods of using same |
CN1638734A (zh) * | 2002-02-22 | 2005-07-13 | 参天制药株式会社 | 微粒结膜下给药的药物释放系统 |
US7128928B2 (en) * | 2002-02-22 | 2006-10-31 | Pharmacia Corporation | Ophthalmic formulation with novel gum composition |
JP2004196787A (ja) * | 2002-12-04 | 2004-07-15 | Santen Pharmaceut Co Ltd | 結膜下デポによるドラッグデリバリーシステム |
EP1568359A4 (en) * | 2002-12-04 | 2011-05-18 | Santen Pharmaceutical Co Ltd | DRUG DELIVERY SYSTEM HAVING SUB-CONJUNCTIVAL DEPOSIT |
US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
CA2839847C (en) * | 2003-06-13 | 2016-03-15 | Masood A. Chowhan | Ophthalmic compositions containing a synergistic combination of two polymers |
WO2005018608A1 (ja) * | 2003-08-20 | 2005-03-03 | Santen Pharmaceutical Co., Ltd. | 微粒子テノン嚢下投与ドラッグデリバリーシステム |
TWI367098B (en) * | 2004-12-23 | 2012-07-01 | Kowa Co | Treating agent for glaucoma |
US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
DE102005035986B4 (de) * | 2005-07-28 | 2009-10-15 | Bausch & Lomb Incorporated | Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat |
EP2334686B1 (en) | 2008-08-28 | 2019-02-27 | President and Fellows of Harvard College | Cortistatin analogues and syntheses therof |
EP2383286A1 (en) | 2010-04-30 | 2011-11-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treatment of retinal degenerative diseases |
JP2012180346A (ja) * | 2011-02-10 | 2012-09-20 | Santen Pharmaceut Co Ltd | 親水性薬物の薬物移行性を改善した水性組成物 |
WO2013124477A1 (en) | 2012-02-24 | 2013-08-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treatment of retinal degenerative diseases |
SG10201808151RA (en) | 2013-12-24 | 2018-10-30 | Harvard College | Cortistatin analogues and syntheses and uses thereof |
EP3294298A4 (en) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin analogues, syntheses, and uses thereof |
WO2017004411A1 (en) | 2015-07-01 | 2017-01-05 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof |
EP3340982B1 (en) | 2015-08-26 | 2021-12-15 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
CN109475756A (zh) | 2016-02-17 | 2019-03-15 | 儿童医疗中心有限公司 | Ffa1(gpr40)作为神经血管生成疾病或病症的治疗标靶 |
MX2018016046A (es) | 2016-06-27 | 2019-05-02 | Achillion Pharmaceuticals Inc | Quinazolina y compuestos indol para tratar trastornos medicos. |
WO2018033854A1 (en) * | 2016-08-15 | 2018-02-22 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition and a method for treating ocular hypertension and glaucoma |
US9867810B1 (en) | 2016-08-19 | 2018-01-16 | Orasis Pharmaceuticals Ltd. | Ophthalmic pharmaceutical compositions and uses relating thereto |
KR102632860B1 (ko) | 2017-03-01 | 2024-02-02 | 아칠리온 파르마세우티칼스 인코포레이티드 | 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물 |
PT3548000T (pt) * | 2017-05-11 | 2021-12-10 | Vyluma Inc | Composiões farmacológicas com atropina |
EP3773576A4 (en) | 2018-03-26 | 2021-12-29 | C4 Therapeutics, Inc. | Cereblon binders for the degradation of ikaros |
WO2020041301A1 (en) | 2018-08-20 | 2020-02-27 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
CN113365617A (zh) | 2018-10-16 | 2021-09-07 | 乔治亚州立大学研究基金会股份有限公司 | 用于医学疾病治疗的一氧化碳前药 |
CA3165309A1 (en) | 2020-03-05 | 2021-09-10 | Christopher G. Nasveschuk | Compounds for targeted degradation of brd9 |
EP4288049A1 (en) * | 2021-02-04 | 2023-12-13 | Sydnexis, Inc. | Ophthalmic compositions for presbyopia |
EP4088713A1 (en) | 2021-05-10 | 2022-11-16 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic pharmaceutical composition comprising atropine |
EP4088714A1 (en) | 2021-05-10 | 2022-11-16 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic pharmaceutical composition comprising atropine |
CN113786380A (zh) * | 2021-09-18 | 2021-12-14 | 华北制药股份有限公司 | 一种硝酸毛果芸香碱眼用凝胶及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6056684B2 (ja) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | 点眼剤 |
US5252318A (en) * | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
FR2678832B1 (fr) * | 1991-07-10 | 1995-03-17 | Europhta Sa Laboratoire | Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation. |
-
1994
- 1994-03-31 SE SE9401108A patent/SE9401108D0/xx unknown
-
1995
- 1995-03-29 CN CN95192185A patent/CN1112918C/zh not_active Expired - Fee Related
- 1995-03-29 SK SK1239-96A patent/SK280492B6/sk not_active IP Right Cessation
- 1995-03-29 CA CA002186734A patent/CA2186734A1/en not_active Abandoned
- 1995-03-29 RU RU96119953A patent/RU2139016C1/ru active
- 1995-03-29 JP JP7525423A patent/JPH10503470A/ja not_active Ceased
- 1995-03-29 AT AT95914362T patent/ATE202921T1/de active
- 1995-03-29 US US08/535,037 patent/US5710182A/en not_active Expired - Lifetime
- 1995-03-29 ES ES95914362T patent/ES2161874T3/es not_active Expired - Lifetime
- 1995-03-29 BR BR9507438A patent/BR9507438A/pt not_active IP Right Cessation
- 1995-03-29 PT PT95914362T patent/PT752847E/pt unknown
- 1995-03-29 MX MX9603918A patent/MX9603918A/es unknown
- 1995-03-29 CZ CZ19962865A patent/CZ290987B6/cs not_active IP Right Cessation
- 1995-03-29 EE EE9600120A patent/EE03661B1/xx unknown
- 1995-03-29 EP EP95914362A patent/EP0752847B1/en not_active Expired - Lifetime
- 1995-03-29 AU AU21389/95A patent/AU694497B2/en not_active Ceased
- 1995-03-29 RO RO96-01877A patent/RO115409B1/ro unknown
- 1995-03-29 KR KR1019960705391A patent/KR100365914B1/ko not_active IP Right Cessation
- 1995-03-29 DE DE69521686T patent/DE69521686T2/de not_active Expired - Lifetime
- 1995-03-29 DK DK95914362T patent/DK0752847T3/da active
- 1995-03-29 DE DE0752847T patent/DE752847T1/de active Pending
- 1995-03-29 HU HU9602691A patent/HU223071B1/hu active IP Right Grant
- 1995-03-29 WO PCT/FI1995/000166 patent/WO1995026711A1/en active IP Right Grant
- 1995-03-29 PL PL95316584A patent/PL179433B1/pl unknown
-
1996
- 1996-09-27 NO NO19964070A patent/NO314434B1/no not_active IP Right Cessation
- 1996-10-16 BG BG100915A patent/BG63145B1/bg unknown
-
1998
- 1998-12-23 HK HK98115146A patent/HK1013953A1/xx not_active IP Right Cessation
-
2001
- 2001-09-28 GR GR20010401621T patent/GR3036763T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9507438A (pt) | Composição oftálmica com viscosidade reduzida | |
SE9401109D0 (sv) | Opthalmic composition II | |
US5945121A (en) | Liposome eye drops | |
KR960700081A (ko) | 콘택트렌즈 용액 보존 시스템(preservative system for contact lens solutions) | |
NZ230663A (en) | Antimicrobial, hypotonic, aqueous contact lens composition | |
CA2183547A1 (en) | Compositions for treating defective cell functions | |
NO940160D0 (no) | Oeyepreparater inneholdende oxicam eller oxicamderivater | |
KR940006575A (ko) | 증가된 안내압 치료를 위한 안구 국소 투여용 약제학적 조성물 | |
WO2009006130A3 (en) | Salt free hyaluronate ophthalmic solution | |
JPS6452727A (en) | Antiallergic eye drop | |
FI963744A (fi) | Alennetun viskositeetin omaava oftalminen koostumus | |
AU2001242398A1 (en) | Contact lens treating method and composition | |
JPS6217973B2 (pt) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer |
Free format text: SANTEN OY (FI) |
|
HJEG | Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law | ||
FF | Decision: intention to grant | ||
B24C | Patent annual fee: request for for restoration |
Free format text: REFERENTE 12A., 13A., 14A., 15A. E 16A. ANUIDADE(S). |
|
B24H | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi) | ||
B24F | Patent annual fee: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AS 12A, 13A, 14A, 15A E 16A ANUIDADES. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |